Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, November 22, 2019
Q BioMed has announced the FDA approval of its contract manufacturer IsoTherapeutics Group.
read more
Purolite announced Praesto® Jetted A50, an agarose-based Protein A chromatography resin, has been incorporated into the commercial manufacturing process of an FDA-approved monoclonal antibody treatment by a contract manufacturing organization.
read more
Thursday, August 08, 2019
Purdue has sold its Treyburn, North Carolina, plant to Novo Nordisk for an undisclosed sum, according to an announcement Purdue CEO Craig Landau sent to the plant’s employees.
read more
Thursday, October 07, 2021
Pulmodyne, Inc., a leading provider of drug atomization delivery, and Alcove Manufacturing and Distribution, Inc., announced the partnership between the two companies to expand distribution, integrate manufacturing, and to continue joint development ...
read more
Monday, November 29, 2021
Provepharm Life Solutions, a French private pharmaceutical company that finds new applications for well-known molecules, today announces that it has been granted FDA (Food and Drug Administration) authorization to produce its own Active ...
read more
ProteoNic and NecstGen announced a partnership for the development of improved viral vector manufacturing for gene therapy applications.
read more
Protagen Protein Services (PPS) announced that it will merge with GeneWerk, an Ampersand portfolio company. With the addition of GeneWerk’s unique capabilities in vector safety, characterization, and functionality analysis, PPS will complement its ...
read more
PromoCell has successfully completed a comprehensive EXCiPACT audit that certifies the company as a manufacturer of pharmaceutical excipients to GMP standards.
read more
Wednesday, August 29, 2018
Promethera Biosciences SA announced Health Canada has confirmed a cGMP compliance status for the company’s production facility in Durham, North Carolina.
read more
Promethera Biosciences and Shibuya announced a strategic collaboration to establish a high-throughput, commercial-scale and clinical-grade cell therapy and regenerative medicine manufacturing platform.
read more
Thursday, October 24, 2013
The loss of drug product during the filtration and fill process presents a major challenge to pharmaceutical and biologics manufacturers worldwide. For Cobra Biologics, a leading CMO providing aseptic manufacture for clinical and commercial supply, ...
read more
ProBioGen AG and Pionyr Immunotherapeutics have announced a second service and license agreement to develop novel antibody therapeutics.
read more
Wednesday, August 17, 2022
ProBioGen closed a Master Service Agreement with NextPoint and initiated development and GMP manufacturing of their lead antibody candidate.
read more
ProBioGen has signed a second clinical immuno-oncology development and manufacturing agreement with Tizona Therapeutics, a privately held immunology company.
read more
Monday, February 14, 2022
ProBioGen has announced a multi-product commercial license agreement with AstraZeneca to use the GlymaxX technology. Following evaluation of the technology under a research license, AstraZeneca will now continue to use GlymaxX and will integrate the ...
read more